Angela Birnbaum, PhD, FAES

Professor, Department of Experimental and Clinical Pharmacology (ECP)

Angela Birnbaum

Contact Info

birnb002@umn.edu

Office Phone 612-624-3158

Fax 612-626-0148

Office Address:
717 Delaware Room 463

Mailing Address:
University of Minnesota
College of Pharmacy
Department of Experimental and Clinical Pharmacology
7-115 Weaver-Densford Hall
308 Harvard St. SE
Minneapolis, MN 55414

Professor, Department of Experimental and Clinical Pharmacology (ECP)

Director of Graduate Studies, Department of Experimental and Clinical Pharmacology (ECP)

Executive Member and Co-founder, Center for Clinical and Cognitive Neuropharmacology

Fellow of The American Epilesy Society (FAES)

Faculty, MS and PhD Programs in Molecular Pharmacology and Therapeutics (MPaT)


Post-doctoral Fellowship, Clinical Neuropharmacology, University of Minnesota, Department of Pharmacy Practice, Minneapolis, Minnesota

PhD of Pharmacology (Neuroscience minor), University of Minnesota - Department of Pharmacology

Bachelor of Science and Medical Technology (BSMT) (chemistry minor), Bachelor of Biology (BS), Ohio Northern University

Medical Technology Internship, St. Rita's Medical Center

Summary

Dr. Birnbaum is a translational researcher studying the pharmacokinetics of neurological medications using pharmacometrics as a tool, and with an emphasis on neuropharmacology and special populations. Her research focuses on the variability of drug concentrations and response and has included investigations in topics related to the elderly, pregnant women, children, and drug addiction. Her research program includes laboratory measurement of biological specimens and investigations in the stability of drugs in vivo and in vitro; pharmacokinetic and pharmacodynamic studies including investigations of bioavailability, pharmacokinetic, pharmacogenomic, drug interaction, and efficacy studies; and the incorporation of pharmacometric modeling and simulation to answer questions in both intensive and sparse sampling settings. Her research is/has been funded by foundations, The National Institutes of Health, instrumentation companies, and the pharmaceutical industry.

Expertise

  • Medical Cannabis
  • Clinical neuropharmacology
  • Antiseizure medications
  • Special populations including pregnant women, children, and elderly
  • Pharmacokinetics/Pharmacodynamics/Pharmacometric analyses
  • Analytical drug measurement and stability studies

    • Research

    Research Summary/Interests

    • Variability in drug exposure and response
    • Pharmacokinetics of antiseizure medications in special populations
    • Pharmacometrics
    • Epilepsy
    • Drug addiction

    Publications